An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

NCT07184996 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

980

Enrollment

INDUSTRY

Sponsor class

Conditions

Ulcerative Colitis

Interventions

DRUG: Duvakitug
DRUG: Placebo

Sponsor

Sanofi

Collaborators

[object Object]